OBIO Orchestra BioMed Holdings Inc
- Stocks
- Healthcare
- NASDAQ: OBIO
Price (delayed)
$2.65
Market cap
$142.98M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.83
Enterprise value
$140.59M
Highlights
The company's gross profit rose by 43% YoY and by 2.1% QoQ
Orchestra BioMed Holdings's revenue has increased by 42% YoY and by 2% QoQ
The equity has plunged by 99% YoY and by 98% from the previous quarter
Orchestra BioMed Holdings's quick ratio has shrunk by 56% YoY and by 38% QoQ
Key stats
What are the main financial stats of OBIO
Market
Valuations
Earnings
Shares outstanding
53.96M
Market cap
$142.98M
Enterprise value
$140.59M
Price to earnings (P/E)
N/A
Price to book (P/B)
344.16
Price to sales (P/S)
34.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
47.75
Revenue
$2.94M
Gross profit
$2.73M
Operating income
-$71.27M
Net income
-$69.7M
EBIT
-$69.66M
EBITDA
-$68.61M
Free cash flow
-$59.7M
Per share
Balance sheet
Liquidity
EPS
-$1.83
EPS diluted
-$1.83
Free cash flow per share
-$1.56
Book value per share
$0.01
Revenue per share
$0.08
TBVPS
$1.12
Total assets
$42.83M
Total liabilities
$42.53M
Debt
$16.35M
Equity
$295,000
Working capital
$18.82M
Debt to equity
55.44
Current ratio
2.1
Quick ratio
1.99
Net debt/EBITDA
0.03
Margins
Efficiency
Dividend
EBITDA margin
-2,330.6%
Gross margin
92.7%
Net margin
-2,367.5%
Operating margin
-2,420.8%
Return on assets
-110%
Return on equity
-289.4%
Return on invested capital
-180.2%
Return on capital employed
-270.4%
Return on sales
-2,366.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OBIO stock price
How has the Orchestra BioMed Holdings stock price performed over time
Intraday
-0.38%
1 week
1.92%
1 month
-12.54%
1 year
-52.17%
YTD
-33.75%
QTD
-1.12%
Financial performance
How have Orchestra BioMed Holdings's revenue and profit performed over time
Revenue
$2.94M
Gross profit
$2.73M
Operating income
-$71.27M
Net income
-$69.7M
Gross margin
92.7%
Net margin
-2,367.5%
The company's gross profit rose by 43% YoY and by 2.1% QoQ
Orchestra BioMed Holdings's revenue has increased by 42% YoY and by 2% QoQ
OBIO's net income is down by 25% YoY and by 5% QoQ
The operating income has declined by 22% year-on-year and by 3.6% since the previous quarter
Price vs fundamentals
How does OBIO's price correlate with its fundamentals
Growth
What is Orchestra BioMed Holdings's growth rate over time
Valuation
What is Orchestra BioMed Holdings stock price valuation
P/E
N/A
P/B
344.16
P/S
34.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
47.75
Orchestra BioMed Holdings's EPS has decreased by 16% YoY and by 2.8% from the previous quarter
The equity has plunged by 99% YoY and by 98% from the previous quarter
Orchestra BioMed Holdings's revenue has increased by 42% YoY and by 2% QoQ
OBIO's price to sales (P/S) is 37% less than its last 4 quarters average of 55.1
Efficiency
How efficient is Orchestra BioMed Holdings business performance
The company's return on assets has shrunk by 82% YoY and by 17% QoQ
Orchestra BioMed Holdings's return on invested capital has shrunk by 82% YoY and by 12% QoQ
OBIO's ROE has dropped by 53% since the previous quarter
Orchestra BioMed Holdings's ROS has increased by 13% YoY
Dividends
What is OBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OBIO.
Financial health
How did Orchestra BioMed Holdings financials performed over time
Orchestra BioMed Holdings's quick ratio has shrunk by 56% YoY and by 38% QoQ
OBIO's current ratio has dropped by 54% year-on-year and by 37% since the previous quarter
The equity has plunged by 99% YoY and by 98% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.